Genetics and ovarian cancer
Advances in genetic testing and knowledge enabling the identification of the ‘faulty’ BRCA1/2 gene mean that women with a family Continue reading
Advances in genetic testing and knowledge enabling the identification of the ‘faulty’ BRCA1/2 gene mean that women with a family Continue reading
I think it must be the season for conferences: In September I went to the American Association for Cancer Research’s Continue reading
We have had a grant call out for the last few months and we have been receiving lots of new Continue reading
Yesterday was a truly remarkable day for Ovarian Cancer Action. We (along with Imperial College, London) held a Symposium at Continue reading
The BBC headline: “US Supreme Court decides that human DNA cannot be patented”, neatly sums up today’s report on the Continue reading
31st May 2013 Today we are issuing a call for new research grant applications. This is a big deal and Continue reading
15th May 2013 Yesterday’s revelation that Angelina Jolie has decided to speak publicly about having the BRCA1 mutation and her Continue reading
10th May 2013 This week saw the first ever World Ovarian Cancer Day – 8th May. The international collaboration was Continue reading